These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37256341)

  • 1. Continuation of therapeutic dose heparin for critically ill patients with COVID-19.
    Bradbury CA; Lawler PR; McVerry BJ; Zarychanski R;
    Intensive Care Med; 2023 Jul; 49(7):873-875. PubMed ID: 37256341
    [No Abstract]   [Full Text] [Related]  

  • 2. The landscape of thromboprophylaxis utilization in critically ill children: sparse and variable.
    Gist KM; Chima RS
    Crit Care Med; 2014 May; 42(5):1317-8. PubMed ID: 24736356
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year.
    Leentjens J; van Haaps TF; Wessels PF; Schutgens REG; Middeldorp S
    Lancet Haematol; 2021 Jul; 8(7):e524-e533. PubMed ID: 33930350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    Davidson BL; Levi MM
    JAMA; 2023 Aug; 330(5):471-472. PubMed ID: 37526726
    [No Abstract]   [Full Text] [Related]  

  • 6. Catastrophic Intracranial Hemorrhage in Two Critically Ill Patients with COVID-19.
    Carroll E; Lewis A
    Neurocrit Care; 2021 Feb; 34(1):354-358. PubMed ID: 32458333
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.
    Goligher EC; Lawler PR; Zarychanski R
    JAMA; 2023 Aug; 330(5):472-473. PubMed ID: 37526722
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.
    Nazy I; Jevtic SD; Moore JC; Huynh A; Smith JW; Kelton JG; Arnold DM
    J Thromb Haemost; 2021 May; 19(5):1342-1347. PubMed ID: 33639037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation Strategies in Critically Ill Patients With SARS-CoV-2 Infection: The Role of Direct Thrombin Inhibitors.
    Pieri M; Quaggiotti L; Fominskiy E; Landoni G; Calabrò MG; Ajello S; Bonizzoni MA; Belletti A; Scandroglio AM
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2961-2967. PubMed ID: 35428549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19.
    Chistolini A; Ruberto F; Alessandri F; Santoro C; Barone F; Cristina Puzzolo M; Ceccarelli G; De Luca ML; Mancone M; Alvaro D; Pulcinelli FM; Martelli M; Foà R; Pugliese F;
    Br J Haematol; 2020 Aug; 190(4):e214-e218. PubMed ID: 32779783
    [No Abstract]   [Full Text] [Related]  

  • 14. The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies.
    Pilia E; Belletti A; Fresilli S; Lee TC; Zangrillo A; Finco G; Landoni G;
    Lung; 2023 Apr; 201(2):135-147. PubMed ID: 36738324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.
    Volteas P; Drakos P; Alkadaa LN; Cleri NA; Asencio AA; Oganov A; Giannopoulos S; Saadon JR; Mikell CB; Rubano JA; Labropoulos N; Tassiopoulos AK; Mofakham S; Bannazadeh M
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1128-1136. PubMed ID: 35716998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit.
    Novelli C; Borotto E; Beverina I; Punzi V; Radrizzani D; Brando B
    Int J Lab Hematol; 2021 Dec; 43(6):1284-1290. PubMed ID: 33855802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients a systematic review and meta-analysis of randomized controlled trials.
    Bonfim LCMG; Guerini IS; Zambon MG; Pires GB; Silva ACF; Gobatto ALN; Lopes MA; Brosnahan SB
    J Crit Care; 2023 Oct; 77():154344. PubMed ID: 37244209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Dragonetti D; Guarini G; Pizzuti M
    Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer anticoagulants in critically ill patients.
    Rajasekhar A; Beyth R; Crowther MA
    Crit Care Clin; 2012 Jul; 28(3):427-51, vii. PubMed ID: 22713616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
    Lewis TC; Cortes J; Altshuler D; Papadopoulos J
    J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.